SRS Sequential Sindilimab in Brain Metastasis of NSLSC
Clinical trial NCT04180501 · UNKNOWN
Trial details
- NCT number
- NCT04180501
- Sponsor
- Xiaorong Dong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2021-09-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.